Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Turnaround Potential
1235.4000 4.10 (0.33%)
NSE Jan 07, 2026 15:31 PM
Volume: 2.4M
High volume today

logo
Aurobindo Pharma Ltd.
28 May 2025
1235.40
0.33%
buy
by Axis Direct
Target: 1500 | Upside : 21.4%
Axis Direct
We maintain our BUY recommendation on Aurobindo Pharma with a TP of Rs 1,500/share.
 
Number of FII/FPI investors decreased from 728 to 700 in Sep 2025 qtr
More from Aurobindo Pharma Ltd.
Recommended
Don't be boring, unless you are an investor
The Baseline | 07 Jan 2026, 07:39PM
India’s electric cars see growth amid tough competition in 2025
The Baseline | 07 Jan 2026, 05:00PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020